Molecular targets of luteolin in cancer

European Journal of Cancer Prevention

Volumn 25, Issue 1, 2016, Pages 65-76

  Tuorkey, Muobarak J ^a,b  

^a Faculty of ScienceDamanhour   (Egypt)

^b Damanhour University   (Egypt)

Author keywords

cell cycle arrest; DNA methylation; Histone modification; PI3K Akt TOR pathway; Wnt catenin signaling

Indexed keywords

BETA CATENIN; BETA1 INTEGRIN; CISPLATIN; DNA TOPOISOMERASE; FOCAL ADHESION KINASE; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; K RAS PROTEIN; LUTEOLIN; MAMMALIAN TARGET OF RAPAMYCIN; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UVOMORULIN; WNT PROTEIN;

ADJUVANT THERAPY; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER PREVENTION; CELL CYCLE REGULATION; DRUG POTENTIATION; EPIGENETICS; FATTY ACID SYNTHESIS; HUMAN; METASTASIS; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR INVASION; ANIMAL; DRUG EFFECTS; METABOLISM; NEOPLASMS;

ANIMALS; HUMANS; LUTEOLIN; MOLECULAR TARGETED THERAPY; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84948661517     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000128     Document Type: Article

References (126)

1. Abdel-Magid AF (2014). Wnt/beta-catenin signaling pathway inhibitors: a promising cancer therapy. ACS Med Chem Lett 5:956-957.
2. Aleksic T, Chitnis MM, Perestenko OV, Gao S, Thomas PH, Turner GD, et al. (2010). Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. Cancer Res 70:6412-6419.
3. Amin AR, Wang D, Zhang H, Peng S, Shin HJ, Brandes JC, et al. (2010). Enhanced anti-tumor activity by the combination of the natural compounds (? )-epigallocatechin-3-gallate and luteolin: potential role of 53. J Biol Chem 285:34557-34565.
4. Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, Gaben AM, et al. (2011). Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol 651:18-25.
5. Beck R, Verrax J, Gonze T, Zappone M, Pedrosa RC, Taper H, et al. (2009). Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death. Biochem Pharmacol 77:375-383.
6. Borchers AH, Sanders LA, Bowden GT (1997). Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact. J Cancer Res Clin Oncol 123:13-20.
7. Cai X, Ye T, Liu C, Lu W, Lu M, Zhang J, et al. (2011). Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells. Toxicol In Vitro 25:1385-1391.
8. Cai X, Lu W, Ye T, Lu M, Wang J, Huo J, et al. (2012). The molecular mechanism of luteolin-induced apoptosis is potentially related to inhibition of angiogenesis in human pancreatic carcinoma cells. Oncol Rep 28:1353-1361.
9. Carbone CJ, Fuchs SY (2014). Eliminative signaling by Janus kinases: role in the downregulation of associated receptors. J Cell Biochem 115:8-16.
10. Chang J, Hsu Y, Kuo P, Kuo Y, Chiang L, Lin C (2005). Increase of Bax/Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sci 76:1883-1893.
11. Cheng WY, Chiao MT, Liang YJ, Yang YC, Shen CC, Yang CY (2013). Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity. Mol Biol Rep 40:5315-5326.
12. Cheng CS, Wang Z, Chen J (2014). Targeting FASN in breast cancer and the discovery of promising inhibitors from natural products derived from traditional chinese medicine. Evid Based Complement Alternat Med 2014:232946.
13. Chen T, Yuan D, Wei B, Jiang J, Kang J, Ling K, et al. (2010). E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells 28:1315-1325.
14. Chen Q, Liu S, Chen J, Zhang Q, Lin S, Chen Z, Jiang J (2012a). Luteolin induces mitochondria-dependent apoptosis in human lung adenocarcinoma cell. Nat Prod Commun 7:29-32.
15. Chen Z, Kong S, Song F, Li L, Jiang H (2012b). Pharmacokinetic study of luteolin, apigenin, chrysoeriol and diosmetin after oral administration of Flos Chrysanthemi extract in rats. Fitoterapia 83:1616-1622.
16. Chen KC, Chen CY, Lin CJ, Yang TY, Chen TH, Wu LC, Wu CC (2013). Luteolin attenuates TGF-beta1-induced epithelial-mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-kappaB-Snail pathway. Life Sci 93:924-933.
17. Chen R, Hollborn M, Grosche A, Reichenbach A, Wiedemann P, Bringmann A, Kohen L (2014). Effects of the vegetable polyphenols epigallocatechin-3-gallate, luteolin, apigenin, myricetin, quercetin, and cyanidin in primary cultures of human retinal pigment epithelial cells. Mol Vis 20: , 242-258.
18. Chian S, Li YY, Wang XJ, Tang XW (2014a). Luteolin sensitizes two oxaliplatinresistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway. Asian Pac J Cancer Prev 15:2911-2916.
19. Chian S, Thapa R, Chi Z, Wang XJ, Tang X (2014b). Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo. Biochem Biophys Res Commun 447:602-608.
20. Chiang CT, Way TD, Lin JK (2007). Sensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing p21(WAF1/CIP1) expression with rapamycin. Mol Cancer Ther 6:2127-2138.
21. Chin YW, Kong JY, Han SY (2013). Flavonoids as receptor tyrosine kinase FLT3 inhibitors. Bioorg Med Chem Lett 23:1768-1770.
22. Chitnis MM, Yuen JS, Protheroe AS, Pollak M, Macaulay VM (2008). The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res 14:6364-6370.
23. Chiu FL, Lin JK (2008). Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Prostate 68:61-71.
24. Chowdhury AR, Sharma S, Mandal S, Goswami A, Mukhopadhyay S, Majumder HK (2002). Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem J 366:653-661.
25. Coleman DT, Bigelow R, Cardelli JA (2009). Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation. Mol Cancer Ther 8:214-224.
26. Dellafiora L, Mena P, Del Rio D, Cozzini P (2014). Modelling the effect of phase II conjugations on topoisomerase I poisoning: pilot study with luteolin and quercetin. J Agric Food Chem 62:5881-5886.
27. Didelot C, Mirjolet JF, Barberi-Heyob M, Ramacci C, Teiten MH, Merlin JL (2003). Oncoprotein expression of E6 and E7 does not prevent 5-fluorouracil (5FU) mediated G1/S arrest and apoptosis in 5FU resistant carcinoma cell lines. Int J Oncol 23:81-87.
28. Ding S, Hu A, Hu Y, Ma J, Weng P, Dai J (2014). Anti-hepatoma cells function of luteolin through inducing apoptosis and cell cycle arrest. Tumour Biol 35:3053-3060.
29. Draganova K, Zemke M, Zurkirchen L, Valenta T, Cantu C, Okoniewski M, et al. (2015). Wnt/beta-catenin signaling regulates sequential fate decisions of murine cortical precursor cells. Stem Cells 33:170-182.
30. Duncan EM, Muratore-Schroeder TL, Cook RG, Garcia BA, Shabanowitz J, Hunt DF, Allis CD (2008). Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell 135:284-294.
31. Erez N, Glanz S, Raz Y, Avivi C, Barshack I (2013). Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors. Biochem Biophys Res Commun 437:397-402.
32. Faivre S, Kroemer G, Raymond E (2006). Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 5:671-688.
33. Fang J, Zhou Q, Shi XL, Jiang BH (2007). Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcinogenesis 28:713-723.
34. Farkas SA, Vymetalkova V, Vodickova L, Vodicka P, Nilsson TK (2014). DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/beta-catenin signaling pathway genes. Epigenomics 6:179-191.
35. Fu J, Chen D, Zhao B, Zhao Z, Zhou J, Xu Y, et al. (2012). Luteolin induces carcinoma cell apoptosis through binding Hsp90 to suppress constitutive activation of STAT3. PLoS One 7:e49194.
36. Garcia-Manero G, Fenaux P (2011). Hypomethylating agents and other novel strategies in myelodysplastic syndromes. J Clin Oncol 29:516-523.
37. Gewirtz DA (2014). An autophagic switch in the response of tumor cells to radiation and chemotherapy. Biochem Pharmacol 90:208-211.
38. Hack SP, Bruey JM, Koeppen H (2014). HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development. Oncotarget 5:2866-2880.
39. Ham S, Kim KH, Kwon TH, Bak Y, Lee DH, Song YS, et al. (2014). Luteolin induces intrinsic apoptosis via inhibition of E6/E7 oncogenes and activation of extrinsic and intrinsic signaling pathways in HPV-18-associated cells. Oncol Rep 31:2683-2691.
40. Hamada S, Horiguchi A, Asano T, Kuroda K, Asakuma J, Ito K, et al. (2014). Prognostic impact of fatty acid synthase expression in upper urinary tract urothelial carcinoma. Jpn J Clin Oncol 44:486-492.
41. Hempel J, Pforte H, Raab B, Engst W, Böhm H, Jacobasch G (1999). Flavonols and flavones of parsley cell suspension culture change the antioxidative capacity of plasma in rats. Nahrung 43:201-204.
42. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Nakanishi R, et al. (2005). The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells. Biochem Biophys Res Commun 333:833-838.
43. Hu C, Cai X, Hu T, Lu W, Cao P (2012). Mechanism of growth inhibition effect of 3?, 4?, 5, 7-tetrahydroxyflavone on A549 cells. Zhongguo Zhong Yao Za Zhi 37:1259-1264.
44. Hwang JT, Park OJ, Lee YK, Sung MJ, Hur HJ, Kim MS, et al. (2011). Anti-tumor effect of luteolin is accompanied by AMP-activated protein kinase and nuclear factor-kappaB modulation in HepG2 hepatocarcinoma cells. Int J Mol Med 28:25-31.
45. Jeon IH, Kim HS, Kang HJ, Lee HS, Jeong SI, Kim SJ, Jang SI (2014). Antiinflammatory and antipruritic effects of luteolin from Perilla (P. frutescens L.) leaves. Molecules 19:6941-6951.
46. Jiang Y, Xie KP, Huo HN, Wang LM, Zou W, Xie MJ (2013). Inhibitory effect of luteolin on the angiogenesis of chick chorioallantoic membrane and invasion of breast cancer cells via downregulation of AEG-1 and MMP-2. Sheng Li Xue Bao 65:513-518.
47. Johnson JL, Gonzalez de Mejia E (2013). Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate antiproliferative effect on human pancreatic cancer cells, in vitro. Food Chem Toxicol 60: , 83-91.
48. Ju W, Wang X, Shi H, Chen W, Belinsky SA, Lin Y (2007). A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factoractivated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol 71:1381-1388.
49. Kagoya Y, Yoshimi A, Kataoka K, Nakagawa M, Kumano K, Arai S, et al. (2014). Positive feedback between NF-kappaB and TNF-alpha promotes leukemiainitiating cell capacity. J Clin Invest 124:528-542.
50. Kang KP, Park SK, Kim DH, Sung MJ, Jung YJ, Lee AS, et al. (2011). Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosis. Nephrol Dial Transplant 26:814-822.
51. Katic M, Kahn CR (2005). The role of insulin and IGF-1 signaling in longevity. Cell Mol Life Sci 62:320-343.
52. Khan HY, Zubair H, Faisal M, Ullah MF, Farhan M, Sarkar FH, et al. (2014). Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action. Mol Nutr Food Res 58:437-446.
53. Kim HY, Jung SK, Byun S, Son JE, Oh MH, Lee J, et al. (2013). Raf and PI3K are the molecular targets for the anti-metastatic effect of luteolin. Phytother Res 27:1481-1488.
54. Kobayashi T, Nakata T, Kuzumaki T (2002). Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett 176:17-23.
55. Krifa M, Alhosin M, Muller CD, Gies JP, Chekir-Ghedira L, Ghedira K, et al. (2013). Limoniastrum guyonianum aqueous gall extract induces apoptosis in human cervical cancer cells involving p16 INK4A re-expression related to UHRF1 and DNMT1 down-regulation. J Exp Clin Cancer Res 32: , 30.
56. Le Marchand L (2002). Cancer preventive effects of flavonoids -a review. Biomed Pharmacother 56:296-301.
57. LeeWJ, Wu LF, Chen WK, Wang CJ, Tseng TH (2006). Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem Biol Interact 160:123-133.
58. Lee EJ, Oh SY, Sung MK (2012). Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Food Chem Toxicol 50: 4136-4143.
59. Lee YH, Morrison BL, Bottaro DP (2014). Synergistic signaling of tumor cell invasiveness by hepatocyte growth factor and hypoxia. J Biol Chem 289:20448-20461.
60. Lim SH, Jung SK, Byun S, Lee EJ, Hwang JA, Seo SG, et al. (2013). Luteolin suppresses UVB-induced photoageing by targeting JNK1 and p90 RSK2. J Cell Mol Med 17:672-680.
61. Lim do Y, Jeong Y, Tyner AL, Park JH (2007). Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am J Physiol Gastrointest Liver Physiol 292:G66-G75.
62. Lim do Y, Cho HJ, Kim J, Nho CW, Lee KW, Park JH (2012). Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells. BMC Gastroenterol 12:9.
63. Limtrakul P, Anuchapreeda S, Buddhasukh D (2004). Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4: 13.
64. Lin Y, Shi R, Wang X, Shen HM (2008). Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8:634-646.
65. Lin YS, Tsai PH, Kandaswami CC, Cheng CH, Ke FC, Lee PP, et al. (2011). Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells. Cancer Sci 102:1829-1839.
66. Lin YC, Tsai PH, Lin CY, Cheng CH, Lin TH, Lee KP, et al. (2013). Impact of flavonoids on matrix metalloproteinase secretion and invadopodia formation in highly invasive A431-III cancer cells. PLoS One 8:e71903.
67. Lin YC, Lin JC, Hung CM, Chen Y, Liu LC, Chang TC, et al. (2014). Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells. J Agric Food Chem 62:5061-5071.
68. Lu XY, Li YH, Xiao XW, Li XB (2013). Inhibitory effects of luteolin on human gastric carcinoma xenografts in nude mice and its mechanism. Zhonghua Yi Xue Za Zhi 93:142-146.
69. Lun M, Zhang PL, Pellitteri PK, Law A, Kennedy TL, Brown RE (2005). Nuclear factor-kappaB pathway as a therapeutic target in head and neck squamous cell carcinoma: pharmaceutical and molecular validation in human cell lines using Velcade and siRNA/NF-kappaB. Ann Clin Lab Sci 35:251-258.
70. Mancini M, Gariboldi MB, Taiana E, Bonzi MC, Craparotta I, Pagin M, Monti E (2014). Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells. Br J Cancer 110:2865-2873.
71. Miean KH, Mohamed S (2001). Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 49:3106-3112.
72. Mirza S, Sharma G, Parshad R, Gupta SD, Pandya P, Ralhan R (2013). Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer 16:23-31.
73. Momtazi-Borojeni AA, Behbahani M, Sadeghi-Aliabadi H (2013). Antiproliferative activity and apoptosis induction of crude extract and fractions of Avicennia marina. Iran J Basic Med Sci 16:1203-1208.
74. Montaser R, Luesch H (2011). Marine natural products: a new wave of drugs? Future Med Chem 3:1475-1489.
75. Müller S, Chen Y, Ginter T, Schäfer C, Buchwald M, Schmitz LM, et al. (2014). SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells. Oncotarget 5:3184-3196.
76. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J (2000). Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98-103.
77. Ong CS, Zhou J, Ong CN, Shen HM (2010). Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3beta-cyclin D1 pathway. Cancer Lett 298:167-175.
78. Ortholand JY, Ganesan A (2004). Natural products and combinatorial chemistry: back to the future. Curr Opin Chem Biol 8:271-280.
79. Ou YC, Kuan YH, Li JR, Raung SL, Wang CC, Hung YY, Chen CJ (2013). Induction of apoptosis by luteolin involving akt inactivation in human 786-o renal cell carcinoma cells. Evid Based Complement Alternat Med 2013: 109105.
80. Ou YC, Li JR, Kuan YH, Raung SL, Wang CC, Hung YY, et al. (2014). Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis. Life Sci 100:110-117.
81. Pandurangan AK, Dharmalingam P, Sadagopan SK, Ramar M, Munusamy A, Ganapasam S (2013). Luteolin induces growth arrest in colon cancer cells through involvement of Wnt/beta-catenin/GSK-3beta signaling. J Environ Pathol Toxicol Oncol 32:131-139.
82. Pandurangan AK, Dharmalingam P, Sadagopan SK, Ganapasam S (2014). Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis. Hum Exp Toxicol 33:1176-1185.
83. Park SW, Cho CS, Jun HO, Ryu NH, Kim JH, Yu YS, et al. (2012). Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production. Invest Ophthalmol Vis Sci 53:7718-7726.
84. Park SH, Park HS, Lee JH, Chi GY, Kim GY, Moon SK, et al. (2013a). Induction of endoplasmic reticulum stress-mediated apoptosis and non-canonical autophagy by luteolin in NCI-H460 lung carcinoma cells. Food Chem Toxicol 56: 100-109.
85. Park W, Amin AR, Chen ZG, Shin DM (2013b). New perspectives of curcumin in cancer prevention. Cancer Prev Res (Phila) 6:387-400.
86. Pollak M (2008). Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915-928.
87. Pratheeshkumar P, Son YO, Budhraja A, Wang X, Ding S, Wang L, et al. (2012). Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. PLoS One 7: e52279.
88. Ptak C, Petronis A (2008). Epigenetics and complex disease: from etiology to new therapeutics. Annu Rev Pharmacol Toxicol 48: , 257-276.
89. Rao RV, Ellerby HM, Bredesen DE (2004). Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 11:372-380.
90. Rengarajan T, Nandakumar N, Rajendran P, Haribabu L, Nishigaki I, Balasubramanian MP (2014). D-Pinitol promotes apoptosis in MCF-7 cells via induction of p53 and Bax and inhibition of Bcl-2 and NF-kappaB. Asian Pac J Cancer Prev 15:1757-1762.
91. Ruan J, Zhang L, Yan L, Liu Y, Yue Z, Chen L, et al. (2012a). Inhibition of hypoxiainduced epithelial mesenchymal transition by luteolin in non-small cell lung cancer cells. Mol Med Rep 6:232-238.
92. Ruan JS, Liu YP, Zhang L, Yan LG, Fan FT, Shen CS, et al. (2012b). Luteolin reduces the invasive potential of malignant melanoma cells by targeting beta3 integrin and the epithelial-mesenchymal transition. Acta Pharmacol Sin 33: 1325-1331.
93. Rushworth SA, Micheau O (2009). Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer. Br J Pharmacol 157: 1186-1188.
94. Shi RX, Ong CN, Shen HM (2004). Luteolin sensitizes tumor necrosis factoralpha-induced apoptosis in human tumor cells. Oncogene 23:7712-7721.
95. Shi RX, Ong CN, Shen HM (2005). Protein kinase C inhibition and X-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Cancer Res 65:7815-7823.
96. Shi R, Huang Q, Zhu X, Ong YB, Zhao B, Lu J, et al. (2007). Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol Cancer Ther 6:1338-1347.
97. Shimoi K, Okada H, Furugori M, Goda T, Takase S, Suzuki M, et al. (1998). Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett 438:220-224.
98. Silva G, Fachin AL, Beleboni RO, França SC, Marins M (2013). In vitro action of flavonoids in the canine malignant histiocytic cell line DH82. Molecules 18:15448-15463.
99. Soncin F, Mohamet L, Eckardt D, Ritson S, Eastham AM, Bobola N, et al. (2009). Abrogation of E-cadherin-mediated cell-cell contact in mouse embryonic stem cells results in reversible LIF-independent self-renewal. Stem Cells 27:2069-2080.
100. Sun T, Xu Z, Wu CT, Janes M, Prinyawiwatkul W, No HK (2007). Antioxidant activities of different colored sweet bell peppers (Capsicum annuum L.). J Food Sci 72:S98-S102.
101. Tai Z, Lin Y, He Y, Huang J, Guo J, Yang L, et al. (2014). Luteolin sensitizes the antiproliferative effect of interferon ?/? by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells. Cell Signal 26:619-628.
102. Thomas GS, Zhang L, Blackwell K, Habelhah H (2009). Phosphorylation of TRAF2 within its RING domain inhibits stress-induced cell death by promoting IKK and suppressing JNK activation. Cancer Res 69:3665-3672.
103. Topcu Z, Ozturk B, Kucukoglu O, Kilinc E (2008). Flavonoids in Helichrysum pamphylicum inhibit mammalian type I DNA topoisomerase. Z Naturforsch C 63:69-74.
104. Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH (2012). Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells. Int J Cancer 130:2812-2823.
105. Uekita T, Fujii S, Miyazawa Y, Hashiguchi A, Abe H, Sakamoto M, Sakai R (2013). Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells. Cancer Sci 104:865-870.
106. Van Attikum H, Gasser SM (2005). The histone code at DNA breaks: a guide to repair? Nat Rev Mol Cell Biol 6:757-765.
107. Verschooten L, Barrette K, Van Kelst S, Rubio Romero N, Proby C, De Vos R, et al. (2012). Autophagy inhibitor chloroquine enhanced the cell death inducing effect of the flavonoid luteolin in metastatic squamous cell carcinoma cells. PLoS One 7:e48264.
108. Vigna E, Comoglio PM (2014). Targeting the oncogenic Met receptor by antibodies and gene therapy. Available at: http://www.nature.com/onc/journal/vaop/ncurrent/full/onc2014142a.html. [Accessed May 2014]
109. Wang F, Gao F, Pan S, Zhao S, Xue Y (2014). Luteolin induces apoptosis, G0/G1 cell cycle growth arrest and mitochondrial membrane potential loss in neuroblastoma brain tumor cells. Available at: http://www.ncbi.nlm.nih.gov/pubmed/?term=Luteolin+induces+apoptosis%2C+G0%2FG1+Cell+cycle+growth+arrest+and+mitochondrial+membrane+potential+loss+in+neu-+roblastoma+brain+tumor+cells. [Accessed May 2014]
110. Wang J, Wu GS (2014). Role of autophagy in cisplatin resistance in ovarian cancer cells. J Biol Chem 289:17163-17173.
111. Wang LM, Xie KP, Huo HN, Shang F, Zou W, Xie MJ (2012a). Luteolin inhibits proliferation induced by IGF-1 pathway dependent ERalpha in human breast cancer MCF-7 cells. Asian Pac J Cancer Prev 13:1431-1437.
112. Wang TT, Wang SK, Huang GL, Sun GJ (2012b). Luteolin induced-growth inhibition and apoptosis of human esophageal squamous carcinoma cell line Eca109 cells in vitro. Asian Pac J Cancer Prev 13:5455-5461.
113. Wang X, Ju W, Renouard J, Aden J, Belinsky SA, Lin Y (2006). 17-Allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factorinduced lung cancer cell death by blocking the nuclear factor-kappaB pathway. Cancer Res 66:1089-1095.
114. Weng CJ, Yen GC (2012). Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev 31:323-351.
115. Wu B, Zhang Q, Shen W, Zhu J (2008). Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line. Mol Cell Biochem 313:125-132.
116. Wu YX, Fang X (2010). Apigenin, chrysin, and luteolin selectively inhibit chymotrypsin-like and trypsin-like proteasome catalytic activities in tumor cells. Planta Med 76:128-132.
117. Wu Z, Peng X, Li J, Zhang Y, Hu L (2013). Constitutive activation of nuclear factor kappaB contributes to cystic fibrosis transmembrane conductance regulator expression and promotes human cervical cancer progression and poor prognosis. Int J Gynecol Cancer 23:906-915.
118. Xavier CP, Lima CF, Preto A, Seruca R, Fernandes-Ferreira M, Pereira-Wilson C (2009). Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. Cancer Lett 281:162-170.
119. Xavier CP, Lima CF, Rohde M, Pereira-Wilson C (2011). Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemother Pharmacol 68:1449-1457.
120. Yan J, Wang Q, Zheng X, Sun H, Zhou Y, Li D, et al. (2012). Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model. Biochem Biophys Res Commun 417: 842-846.
121. Yang MY, Wang CJ, Chen NF, Ho WH, Lu FJ, Tseng TH (2014). Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3. Chem Biol Interact 213:60-68.
122. Yu J, Peng Y, Wu LC, Xie Z, Deng Y, Hughes T, et al. (2013). Curcumin downregulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS One 8:e55934.
123. Zhang R, Luo D, Miao R, Bai L, Ge Q, Sessa WC, Min W (2005). Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. Oncogene 24:3954-3963.
124. Zhang Y, Moerkens M, Ramaiahgari S, de Bont H, Price L, Meerman J, van de Water B (2011). Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. Breast Cancer Res 13:R52.
125. Zhao JJ, Carrasco RD (2014). Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapy. Cancer Res 74:5351-5358.
126. Zhou Q, Yan B, Hu X, Li XB, Zhang J, Fang J (2009). Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin. Mol Cancer Ther 8: 1684-1691.